NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Wednesday that its fourth quarter revenues fell 23 percent year over year, largely due to a drop in sample accessions compared to same quarter last year.

For the three months ended Dec. 31, the company reported that its Q4 revenues fell to $995,226, compared to $1.3 million for Q4 2016. This included $61,000 from development services testing and $935,000 from commercial tests.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.